Codexis plans to use stock offering proceeds to fund working capital and R&D
CDXS•Codexis launches underwritten stock offering
Codexis launched an underwritten public offering of common stock, aiming to raise new capital subject to market conditions.
Net proceeds are planned for working capital, general corporate purposes, research and development, and business activities.
Underwriters will have a 30-day option to buy up to 15% additional shares on the same terms.
